The application for an operating licence provided for in Article L. 613-17-1 shall be addressed to the Minister responsible for industrial property. It shall include the information mentioned in Article 6 of Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems. The application shall identify the patents and, where they exist, the supplementary protection certificates for which an exploitation licence is requested.
The Minister shall notify the application without delay to the owner of the patent for the invention and, where applicable, to the holders of licences entered in the National Patent Register, who shall have a period of fifteen days from receipt of this notification to submit observations.